Viral-mediated gene therapy for spinal cord injury (SCI) from a translational neuroanatomical perspective

Andrew P Tosolini1, Renée Morris2

  • 1Translational Neuroscience Facility, School of Medical Sciences, the University of New South Wales (UNSW Australia), Sydney, Australia; Current address for Tosolini AP: Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, University College London, London, UK.

Abstract

No abstract available in PubMed .